{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:31Z","timestamp":1789560751048,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100773","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:17:44Z","timestamp":1784812664000},"page":"100773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel adeno-associated viral vector derived from human spleen isolate AAV.hu.S17"],"prefix":"10.1016","volume":"24","author":[{"given":"Wenyan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3685","key":"10.1016\/j.jgeb.2026.100773_bb0005","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-associated defective virus particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100773_bb0010","article-title":"Synthetic biology: emerging concepts to design and advance adeno-associated viral vectors for gene therapy","volume":"8","author":"Wagner","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jgeb.2026.100773_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108433","article-title":"The state of technological advancement to address challenges in the manufacture of rAAV gene therapies","volume":"76","author":"Destro","year":"2024","journal-title":"Biotechnol Adv"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100773_bb0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-mediated gene therapy for research and therapeutic purposes","volume":"1","author":"Samulski","year":"2014","journal-title":"Annu Rev Virol"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100773_bb0025","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.ymthe.2024.10.017","article-title":"Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: a comprehensive review","volume":"32","author":"Wang","year":"2024","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100773_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jgeb.2026.100773_bb0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J Control Release"},{"issue":"21","key":"10.1016\/j.jgeb.2026.100773_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112806","article-title":"AAV13 enables precise targeting of local neural populations","volume":"23","author":"Han","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100773_bb0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV serotypes and their applications in gene therapy: an overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100773_bb0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tim.2021.09.005","article-title":"Adeno-associated virus (AAV) cell entry: structural insights","volume":"30","author":"Meyer","year":"2022","journal-title":"Trends Microbiol"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100773_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076310","article-title":"Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain","volume":"8","author":"Aschauer","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100773_bb0060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): where are we, and how did we get Here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu Rev Virol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100773_bb0065","first-page":"47","article-title":"Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in RPE65","volume":"37","author":"Lorenz","year":"2025","journal-title":"Med Genet"},{"issue":"13","key":"10.1016\/j.jgeb.2026.100773_bb0070","first-page":"1427","article-title":"Eladocagene Exuparvovec: First Approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jgeb.2026.100773_bb0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid modifications for targeting and improving the efficacy of AAV vectors","volume":"12","author":"B\u00fcning","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100773_bb0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.gim.2021.10.013","article-title":"The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: a systematic review","volume":"24","author":"Britten-Jones","year":"2022","journal-title":"Genet Med"},{"issue":"17\u201318","key":"10.1016\/j.jgeb.2026.100773_bb0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/hum.2022.159","article-title":"Update on viral gene therapy clinical trials for retinal diseases","volume":"33","author":"Cheng","year":"2022","journal-title":"Hum Gene Ther"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100773_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molmed.2022.01.003","article-title":"AAV capsid design: a goldilocks challenge","volume":"28","author":"Zolotukhin","year":"2022","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100773_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100773_bb0100","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/s41467-020-17047-1","article-title":"Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties","volume":"11","author":"Hsu","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100773_bb0105","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1038\/s41467-023-39554-7","article-title":"AAV11 enables efficient retrograde targeting of projection neurons and enhances astrocyte-directed transduction","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.jgeb.2026.100773_bb0110","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1128\/JVI.79.23.14781-14792.2005","article-title":"Molecular characterization of adeno-associated viruses infecting children","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100773_bb0115","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jgeb.2026.100773_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.omtm.2018.05.005","article-title":"A recombinant Baculovirus efficiently generates recombinant adeno-associated virus vectors in cultured insect cells and larvae","volume":"10","author":"Wu","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"20","key":"10.1016\/j.jgeb.2026.100773_bb0125","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","article-title":"Identification of a heparin-binding motif on adeno-associated virus type 2 capsids","volume":"77","author":"Kern","year":"2003","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100773_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00637-25","article-title":"Retinal transduction profiling of diverse AAV serotypes via intravitreal injection","volume":"99","author":"Zhang","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.jgeb.2026.100773_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2022.1054069","article-title":"Strategies to improve safety profile of AAV vectors","volume":"2","author":"Suoranta","year":"2022","journal-title":"Front Mol Med"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100773_bb0140","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","article-title":"AAV vectors: the Rubik\u2019s cube of human gene therapy","volume":"30","author":"Pupo","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jgeb.2026.100773_bb0145","article-title":"AAV for gene therapy in ocular diseases: progress and prospects","volume":"6","author":"He","year":"2023","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.jgeb.2026.100773_bb0150","article-title":"AAV-mediated gene therapy: advancing cardiovascular disease treatment","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100773_bb0155","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1134\/S0006297923120179","article-title":"Viral vectors in gene replacement therapy","volume":"88","author":"Minskaia","year":"2023","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jgeb.2026.100773_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jgeb.2026.100773_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001263","article-title":"rAAV immunogenicity, toxicity, and durability in 255 clinical trials: a meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front Immunol"},{"issue":"7588","key":"10.1016\/j.jgeb.2026.100773_bb0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","article-title":"An essential receptor for adeno-associated virus infection","volume":"530","author":"Pillay","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100773_bb0175","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ymthe.2025.01.041","article-title":"A comprehensive atlas of AAV tropism in the mouse","volume":"33","author":"Walkey","year":"2025","journal-title":"Mol Ther"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:59:41Z","timestamp":1789559981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26001174"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100773","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel adeno-associated viral vector derived from human spleen isolate AAV.hu.S17","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100773"}}